Page 16 - Edwin Hardeman News Today

Bayer sees no fundamental changes in its outlook, but investors are less optimistic

4 Min Read FRANKFURT (Reuters) -Bayer shares dropped as much as 5% on Thursday after a U.S. judge rejected its plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer. The German group called into question the future sale of glyphosate-based products to gardeners in the U.S., and said it would review plans to settle around 30,000 legal claims, after the judge called Bayer’s plan to end years of litigation “unreasonable” on Wednesday. “We wi...

We are stepping on Jerri-Lynn’s toes a bit, since she has been following Monsanto litigation closely. Today we are providing an update on a effort to settle a large group of pending and potential cases. The short version is that this effort, like an earlier attempt, was rejected by Federal judge in the Northern District of California. We’ve embedded his order at the end of this post. To catch you up on this sorry story, Bayer bought Monsanto, despite its known glysophate litigation risks, a...

A federal judge yesterday rejected an attempt by an agribusiness giant to settle cancer claims related to its Roundup weedkiller.

Environmental News For The Week Ending 23May 2019 This is a collection of interesting news articles about the environment and related topics published last week. This is usually a Tuesday evening regular post at GEI (but can be posted at other times). Please share this article - Go to very top of page, right hand side, for social media buttons. Note: Because of the high volume of news regarding the coronavirus outbreak, that news has been published separately: Covid totals continue to fall, bo...

5.5 years after first Roundup lawsuits were filed, pharmaceutical company Bayer—which purchased Monsanto in 2018—is still in the process of resolving claims. Most recently in Ninth Circuit to request preliminary approval of a settlement deal with a total value of $2 billion.

A US judge on Wednesday rejected a deal to settle future Roundup cancer suits, saying it does more for weed-killer maker Bayer than for those who fall ill. The agreement would apply to Roundup users already diagnosed with NHL but who have yet to sue the company, as well as anyone who used the weed killer before February of this year but have yet to be diagnosed with the illness.

EPA to review Roundup weed killer to assess potential ‘ecological risks’ (FILES) In this file photo taken on September 1, 2019, Roundup weed killer that is the subject of thousands of lawsuits in the US, is pictured on sale in Los Angeles, California. - A US federal court in San Francisco on May 14, 2021 denied an appeal by Monsanto in the cancer trial over its Roundup weedkiller and upheld an award of $25 million in damages. (Photo by Mark RALSTON / AFP) (Photo by MARK RALSTON/AFP via Gett...

The Court affirms a jury verdict and damages award in the first major multidistrict litigation trial over Monsanto pesticide Roundup.

EPA to review Roundup weedkiller to assess potential ecological risks FacebookTwitterEmail (FILES) In this file photo taken on September 1, 2019, Roundup weed killer that is the subject of thousands of lawsuits in the US, is pictured on sale in Los Angeles, California. - A US federal court in San Francisco on May 14, 2021 denied an appeal by Monsanto in the cancer trial over its Roundup weedkiller and upheld an award of $25 million in damages. (Photo by Mark RALSTON / AFP) (Photo by MARK RALSTO...